<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195372</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Systemic lupus erythematosus nephritis and COVID-19 disease.</ArticleTitle><Pagination><StartPage>2335</StartPage><EndPage>2340</EndPage><MedlinePgn>2335-2340</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06634-4</ELocationID><Abstract><AbstractText>Of the more than 20 studies published on SLE patients with COVID-19, none of the studies focused on lupus nephritis. We report the outcomes of renal biopsy-proven systemic lupus erythematosus (SLE) nephritis patients after COVID-19 disease. Our institute has been declared as a state COVID-19 hospital in the last week of March 2020. From then till now, we have admitted and managed COVID-19 patients from several districts of Andhra Pradesh and neighbouring states. We collected the data of patients with SLE nephritis contemporaneously from admission to the outcomes on a computerised proforma. We had identified sixteen patients with SLE nephritis who were admitted with COVID-19 disease. Of them, fourteen were females and two were males. The mean age was 29.3 years. Out of sixteen patients, seven required a mechanical ventilator and dialysis and eventually succumbed. One more patient died due to disseminated tuberculosis. Our results suggested that with an approximately 50% mortality rate, the COVID-19 disease had a calamitous effect on SLE nephritis patients. Key Points &#x2022; We identified the significant risk factors for mortality: younger age, higher serum creatinine at presentation, higher CT severity score and lower serum albumin. &#x2022; After the analysis done for this article, we decided to reduce the medications for SLE nephritis to prednisolone 10 mg/day when COVID-19 disease is contracted.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gayathri</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monica</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakshmi</LastName><ForeName>P Aishwarya</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathini</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>N Prasanna</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram</LastName><Identifier Source="ORCID">0000-0002-3523-3547</Identifier><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India. ram_5_1999@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>V Siva</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Sri Venkateswara Institute of Medical Sciences, Tirupati, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-dsDNA titre</Keyword><Keyword MajorTopicYN="N">COVID-19 disease</Keyword><Keyword MajorTopicYN="N">Dialysis</Keyword><Keyword MajorTopicYN="N">Nephritis</Keyword><Keyword MajorTopicYN="N">Renal biopsy</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>11</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195372</ArticleId><ArticleId IdType="pmc">PMC10189213</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06634-4</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06634-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol. 2020;11:589474. doi: 10.3389/fimmu.2020.589474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589474</ArticleId><ArticleId IdType="pmc">PMC7661632</ArticleId><ArticleId IdType="pubmed">33193418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res. 2021;232:13&#x2013;36. doi: 10.1016/j.trsl.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7749645</ArticleId><ArticleId IdType="pubmed">33352298</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer ME, Kaelber DC, Antonelli MJ. Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis. Ann Rheum Dis. 2020;2020:218500. doi: 10.1136/annrheumdis-2020-218500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218500</ArticleId><ArticleId IdType="pubmed">32759263</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Chen Z, Wang Y, Han L, Qin K, Huang W, Huang Y, Wang H, Shen P, Ba X, Lin W, Dong H, Zhang M, Tu S. Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study. Ann Rheum Dis. 2020;79(9):1163&#x2013;1169. doi: 10.1136/annrheumdis-2020-217425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217425</ArticleId><ArticleId IdType="pmc">PMC7316114</ArticleId><ArticleId IdType="pubmed">32546598</ArticleId></ArticleIdList></Reference><Reference><Citation>Holubar J, Le Quintrec M, Letaief H, Faillie JL, Pers YM, Jorgensen C. Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak. Ann Rheum Dis. 2021;80(4):e56. doi: 10.1136/annrheumdis-2020-217919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217919</ArticleId><ArticleId IdType="pubmed">32513650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hi&#xe9; M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivi&#xe8;re E, S&#xe8;ne D, S&#xe8;ve P, Mor&#xe9;lot-Panzini C, Viallard JF, Virot JS, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. 2020;79(6):837&#x2013;839. doi: 10.1136/annrheumdis-2020-217566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217566</ArticleId><ArticleId IdType="pubmed">32332072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartshteyn Y, Askanase AD, Schmidt NM, Bernstein EJ, Khalili L, Drolet R, Broderick RJ, Geraldino-Pardilla L, Kapoor T. COVID-19 and systemic lupus erythematosus: a case series. Lancet Rheumatol. 2020;2(8):e452&#x2013;e454. doi: 10.1016/S2665-9913(20)30161-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30161-2</ArticleId><ArticleId IdType="pmc">PMC7250558</ArticleId><ArticleId IdType="pubmed">32835249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz R, Masson M, Kim MY, Myers B, Haberman RH, Castillo R, Scher JU, Guttmann A, Carlucci PM, Deonaraine KK, Golpanian M, Robins K, Chang M, Belmont HM, Buyon JP, Blazer AD, Saxena A, Izmirly PM, Investigators NYUWARCOV. Leveraging the United States epicenter to provide insights on COVID-19 in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2020;72(12):1971&#x2013;1980. doi: 10.1002/art.41450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41450</ArticleId><ArticleId IdType="pmc">PMC7941257</ArticleId><ArticleId IdType="pubmed">32715660</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredi M, Cavazzana I, Moschetti L, Andreoli L, Franceschini F, Brescia Rheumatology COVID-19 Study Group COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study. Lancet Rheumatol. 2020;2(9):e549&#x2013;e556. doi: 10.1016/S2665-9913(20)30169-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30169-7</ArticleId><ArticleId IdType="pmc">PMC7302769</ArticleId><ArticleId IdType="pubmed">32838307</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques C, Pinheiro MM, Reis Neto ET, Dantas AT, Ribeiro FM, Melo AKG. COVID-19 in patients with rheumatic diseases: what is the real mortality risk? Ann Rheum Dis. 2022;81(8):e134. doi: 10.1136/annrheumdis-2020-218388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218388</ArticleId><ArticleId IdType="pubmed">32660978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez GA, Moroni L, Della-Torre E, Gerosa M, Beretta L, Bozzolo EP, Dagna L. Systemic lupus erythematosus and COVID-19: what we know so far. Ann Rheum Dis. 2023;82(3):e73. doi: 10.1136/annrheumdis-2020-218601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218601</ArticleId><ArticleId IdType="pubmed">32859611</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J, Kandane-Rathnayake R, Louthrenoo W, Hoi A, Golder V, Chen YH, Luo SF, Wu YJ, Hamijoyo L, Lau CS, Navarra S, Zamora L, Tee M, Flora A, Jr, Li ZG, An Y, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Kikuchi J, Takeuchi T, Basnayake D, Goldblatt F, Chan M, Ng KPL, Bae SC, Oon S, O'Neill S, Gibson K, Kumar S, Law AHN, Tugnet N, Tanaka Y, Nikpour M, Morand E, Lateef A. COVID-19 infection in patients with systemic lupus erythematosus: data from the Asia Pacific Lupus Collaboration. Int J Rheum Dis. 2020;23(9):1255&#x2013;1257. doi: 10.1111/1756-185X.13937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13937</ArticleId><ArticleId IdType="pmc">PMC7461525</ArticleId><ArticleId IdType="pubmed">32841510</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos CS, Morales CM, &#xc1;lvarez ED, Castro C&#xc1;, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020;39(9):2789&#x2013;2796. doi: 10.1007/s10067-020-05301-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05301-2</ArticleId><ArticleId IdType="pmc">PMC7383119</ArticleId><ArticleId IdType="pubmed">32720259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez GA, Gerosa M, Beretta L, Bellocchi C, Argolini LM, Moroni L, Della Torre E, Artusi C, Nicolosi S, Caporali R, Bozzolo EP, Dagna L, SMILE, Milan Lupus Consortium COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients. Semin Arthritis Rheum. 2020;50(5):1150&#x2013;1157. doi: 10.1016/j.semarthrit.2020.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.06.012</ArticleId><ArticleId IdType="pmc">PMC7836639</ArticleId><ArticleId IdType="pubmed">32927376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC, COVID-19 Global Rheumatology Alliance Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859&#x2013;866. doi: 10.1136/annrheumdis-2020-217871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217871</ArticleId><ArticleId IdType="pmc">PMC7299648</ArticleId><ArticleId IdType="pubmed">32471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Yao B, Yan M, Su KE, Wang H, Xu C. The plight of patients with lupus nephritis during the outbreak of COVID-19 in Wuhan. China. J Rheumatol. 2020;47(9):1452. doi: 10.3899/jrheum.200452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200452</ArticleId><ArticleId IdType="pubmed">32385088</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Chen Z, Wang Y, Han L, Qin K, Huang W, Huang Y, Wang H, Shen P, Ba X, Lin W, Dong H, Zhang M, Tu S. Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study. Ann Rheum Dis. 2020;79(9):1163&#x2013;1169. doi: 10.1136/annrheumdis-2020-217425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217425</ArticleId><ArticleId IdType="pmc">PMC7316114</ArticleId><ArticleId IdType="pubmed">32546598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendebien Z, von Frenckell C, Ribbens C, Andr&#xe9; B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Ann Rheum Dis. 2021;80(6):e94. doi: 10.1136/annrheumdis-2020-218244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218244</ArticleId><ArticleId IdType="pubmed">32586921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Ann Rheum Dis. 2020;79(10):1382&#x2013;1383. doi: 10.1136/annrheumdis-2020-217717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217717</ArticleId><ArticleId IdType="pubmed">32398281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace B, Washer L, Marder W, Kahlenberg JM. Patients with lupus with COVID-19: University of Michigan experience. Ann Rheum Dis. 2021;80(3):e35. doi: 10.1136/annrheumdis-2020-217794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217794</ArticleId><ArticleId IdType="pubmed">32475835</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos CS, Morales CM, &#xc1;lvarez ED, Castro C&#xc1;, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020;39(9):2789&#x2013;2796. doi: 10.1007/s10067-020-05301-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05301-2</ArticleId><ArticleId IdType="pmc">PMC7383119</ArticleId><ArticleId IdType="pubmed">32720259</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero F, Mart&#xed;nez-Barrio J, Serrano-Benavente B, Gonz&#xe1;lez T, Rivera J, Molina Collada J, Castrej&#xf3;n I, &#xc1;lvaro-Gracia J. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int. 2020;40(10):1593&#x2013;1598. doi: 10.1007/s00296-020-04676-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04676-4</ArticleId><ArticleId IdType="pmc">PMC7425254</ArticleId><ArticleId IdType="pubmed">32794113</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, Vaglio A, Prisco D. SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev. 2020;19(7):102575. doi: 10.1016/j.autrev.2020.102575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102575</ArticleId><ArticleId IdType="pmc">PMC7200134</ArticleId><ArticleId IdType="pubmed">32376395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, Cozzi G, Depascale R, Zanatta E, Gasparotto M, Benvenuti F, Bindoli S, Gatto M, Felicetti M, Ortolan A, Campaniello D, Larosa M, Lorenzin M, Ramonda R, Sfriso P, Schiavon F, Iaccarino L, Doria A. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun. 2020;112:102502. doi: 10.1016/j.jaut.2020.102502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102502</ArticleId><ArticleId IdType="pmc">PMC7832807</ArticleId><ArticleId IdType="pubmed">32527675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakthiswary R, Chuah HY, Chiang KS, Liew YS, Muhammad Aizat NA. COVID-19 in systemic lupus erythematosus: a pooled analysis and systematic review of case reports and series. Lupus. 2021;30(12):1946&#x2013;1954. doi: 10.1177/09612033211045057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211045057</ArticleId><ArticleId IdType="pubmed">34565208</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>